American Portfolios Advisors’s Alaunos Therapeutics TCRT Stock Holding History

American Portfolios Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.61K	Hold	14	–	–	﹤0.01%	2949
2022 Q2	$2.6K	Hold	14	–	–	﹤0.01%	3061
2022 Q1	$1.37K	Hold	14	–	–	﹤0.01%	3302
2021 Q4	$2.29K	Hold	14	–	–	﹤0.01%	3141
2021 Q3	$3.82K	Buy	14 +2	+17%	+$612	﹤0.01%	2957
2021 Q2	$4.75K	Hold	12	–	–	﹤0.01%	2833
2021 Q1	$6.48K	Buy	12 +3	+33%	+$1.87K	﹤0.01%	2591
2020 Q4	$3.28K	Hold	9	–	–	﹤0.01%	2568
2020 Q3	$3.28K	Hold	9	–	–	﹤0.01%	2435
2020 Q2	$4.26K	Hold	9	–	–	﹤0.01%	2292
2020 Q1	$3.19K	Hold	9	–	–	﹤0.01%	2252
2019 Q4	$6.14K	Hold	9	–	–	﹤0.01%	2201
2019 Q3	$5.56K	Hold	9	–	–	﹤0.01%	2161
2019 Q2	$7.6K	Hold	9	–	–	﹤0.01%	2008
2019 Q1	$5.02K	Hold	9	–	–	﹤0.01%	2098
2018 Q4	$2.44K	Buy	+9	New	+$3.56K	﹤0.01%	2085
2018 Q3	–	Hold	0	–	–	–	2405
2018 Q2	–	Hold	0	–	–	–	2374
2018 Q1	–	Hold	0	–	–	–	2302
2017 Q4	–	Hold	0	–	–	–	2253

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

American Portfolios Advisors's TCRT Position: Q3 2022 in Review

American Portfolios Advisors held its Alaunos Therapeutics (TCRT) position steady in Q3 2022 at 14 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

American Portfolios Advisors first reported a position in TCRT in Q4 2018 and has held it in 16 quarters since. The position peaked at $7.6K in Q2 2019. 125 funds tracked by Wall St. Rank hold TCRT as of Q3 2022.

American Portfolios Advisors held 14 shares of Alaunos Therapeutics worth $3.61K as of Q3 2022.
American Portfolios Advisors left its Alaunos Therapeutics share count unchanged in Q3 2022.
Alaunos Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2949 holding.
American Portfolios Advisors first reported a position in Alaunos Therapeutics in Q4 2018 and has held it in 16 quarters since.
American Portfolios Advisors's Alaunos Therapeutics position peaked at $7.6K in Q2 2019.
125 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.